Evidence map›Paper›PMID 41256534›Full record

ArticlebioRxiv : the preprint server for biology2025

A recurrent sequencing artifact on Illumina sequencers with two-color fluorescent dye chemistry and its impact on somatic variant detection.

Beverly J Fu, Vinayak V Viswanadham, Dominika Maziec, Hu Jin, Peter J Park

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Beverly J FuHarvard College, Cambridge, MA, 02138, USA.ORCID 0009-0005-5156-4070
Vinayak V ViswanadhamDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0000-0002-0236-6490
Dominika MaziecDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0009-0009-4427-7267
Hu JinDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0000-0002-8657-5686
Peter J ParkDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0000-0001-9378-960X

Funding

Development and Application of Computational Methods for Single Cell DNA Sequencing DataR01HG012573 · NHGRI · HARVARD MEDICAL SCHOOL · PI PARK, PETER J · 2022 to 2025
$2.7M
Mutational signature analysis: methods and applications to the clinicR01CA269805 · NCI · HARVARD MEDICAL SCHOOL · PI Peter J Park · 2022 to 2026
$2.2M
Characterizing mechanisms and consequences of intergenic transcription in human cancersF31CA264958 · NCI · HARVARD MEDICAL SCHOOL · PI VISWANADHAM, VINAYAK VENKATASESHA · 2021 to 2022
$60k
NCI NIH HHS F31 CA264958NCI NIH HHS R01 CA269805NHGRI NIH HHS R01 HG012573
6 · The paper itself

Abstract

Background: The sequencing-by-synthesis technology by Illumina, Inc. enables efficient and scalable readouts of mutations from genomic data. To enhance sequencing speed and efficiency, Illumina has shifted from the four-color base calling chemistry of the HiSeq series to a two-color fluorescent dye chemistry in the NovaSeq series. Benchmarking sequencing artifacts due to biases in the newer chemistry is important to evaluate the quality of identified mutations. Results: We re-analyzed a series of whole-genome sequencing experiments in which the same samples were sequenced on the NovaSeq 6000 (two-color) and HiSeq X10 (four-color) platforms by independent groups. In several samples, we observed a higher frequency of T-to-G and A-to-C substitutions ("T>G") at the read level for NovaSeq 6000 versus HiSeq X10. As the per-base error rate is still low, the artifactual substitutions have a negligible effect in identifying germline or high variant allele frequency (VAF) somatic mutations. However, such errors can confound the detection of low-VAF somatic variants in high-depth sequencing samples, particularly in studies of mosaic mutations in normal tissues, where variants have low read support and are called without a matched normal. The artifactual T>G variant calls disproportionately occur at NT[TG] trinucleotides, and we leveraged this observation to bioinformatically reduce the T>G excess in somatic mutation callsets. Conclusions: We identified a recurrent artifact specific to the Illumina two-color chemistry platform on the NovaSeq 6000 with the potential to contaminate low-VAF somatic mutation calls. Thus, an unexpected enrichment of T>G mutations in mosaicism studies warrants caution.

Indexed as

Illumina NovaSeq 6000mosaic mutationsNext-generation sequencingsequencing artifactssomatic mutations

Identifiers

PMID41256534
PMCPMC12621940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.